Thangapalam Jawahar Abraham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thangapalam Jawahar Abraham has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Prasanna Kumar Patil
24 shared publicationsHarresh Adikesavalu
West Bengal University of Animal and Fishery Sciences
21 shared publicationsSayani Banerjee
Department of Aquatic Animal Health, Faculty of Fishery Sciences, West Bengal University of Animal and Fishery Sciences, Chakgaria, Kolkata, India
17 shared publicationsAvijit Patra
Department of Aquatic Animal Health, Faculty of Fishery Sciences, West Bengal University of Animal and Fishery Sciences, Chakgaria, Kolkata, West Bengal, India
16 shared publications- Prasanna Kumar Patil
ICAR‐Central Institute of Brackishwater Aquaculture Chennai India
14 shared publications Jasmine Singha
Department of Aquatic Animal Health, West Bengal University of Animal and Fishery Sciences, Chakgaria, Kolkata 700094, India
13 shared publications
Latest Publications
- 7 October 2026
- Published by Taylor & Francis in Drug and Chemical Toxicology
- p. 1-16
Praziquantel residue profile and integrated biomarker response-based risk assessment for Nile tilapia Oreochromis niloticus
1. The fisheries and aquaculture sector is one of the fastest-growing domains in food production. World production from fisheries and aquaculture reached a new high of 235 million tonnes in 2024, a...
- 7 October 2026
- Published by Taylor & Francis in Drug and Chemical Toxicology
- p. 1-16
Praziquantel residue profile and integrated biomarker response-based risk assessment for Nile tilapia Oreochromis niloticus
1. The fisheries and aquaculture sector is one of the fastest-growing domains in food production. World production from fisheries and aquaculture reached a new high of 235 million tonnes in 2024, a...
- Open Access
- 22 September 2026
- Published by Elsevier in The Veterinary Journal: Pharmacology & Toxicology
- Vol. 1 (4)
Pharmacokinetics and tissue distribution of oxolinic acid in Nile tilapia Oreochromis niloticus following a single oral gavage under tropical conditions
- 22 September 2026
- Published by Elsevier in The Veterinary Journal: Pharmacology & Toxicology
- Vol. 1 (4)
Open AccessPharmacokinetics and tissue distribution of oxolinic acid in Nile tilapia Oreochromis niloticus following a single oral gavage under tropical conditions
- Open Access
- 2 June 2026
- Published by BdFISH in Journal of Fisheries
- Vol. 14 (3) , 143203
Alterations in Nile tilapia Oreochromis niloticus erythrometry as sensitive indicators of dietary fluoroquinolone antibiotic enrofloxacin toxicity
The use of antibiotics in aquaculture poses significant health risks to fish and consumers. Adopting and validating a standard, non-lethal, and cost-effective method to monitor fish health is essential. This study investigated the impact of fluoroquinolone antibiotic enrofloxacin (ENF) on the erythrocyte cellular and nuclear morphometric anomalies in Oreochromis niloticus. Fish were fed graded doses of ENF at 0 mg, 10 mg, 30 mg, 50 mg and 100 mg kg biomass–1 day–1 for 15 consecutive days, followed by a 21-day post-dosing observation. The results revealed significant alterations in erythrocyte morphometric characteristics, such as major and minor axes, volume, surface area, cell to nucleus ratio, and surface area to volume ratio due to dietary ENF, indicating its cytotoxicity and perilous effects on fish erythrocytes. The nucleus was shrinking more significantly than the cell under treatment-induced stress. On day 15 of dosing, the surface area to volume ratio increased in the dosing groups, except for the 10× group, which represented an adaptive response in the fish to facilitate greater area for gas exchange to occur. However, the observed dose- and time-dependent erythro-morphometry was reversible once dosing was suspended. The results showed that fish erythrometric abnormalities, a relatively unexplored area of clinical science, can serve as important biomarkers or sensitive indicators of toxicity of veterinary medicinal products in assessing the physiological health status of cultured aquatic organisms.
- 2 June 2026
- Published by BdFISH in Journal of Fisheries
- Vol. 14 (3) , 143203
Open AccessAlterations in Nile tilapia Oreochromis niloticus erythrometry as sensitive indicators of dietary fluoroquinolone antibiotic enrofloxacin toxicity
The use of antibiotics in aquaculture poses significant health risks to fish and consumers. Adopting and validating a standard, non-lethal, and cost-effective method to monitor fish health is essential. This study investigated the impact of fluoroquinolone antibiotic enrofloxacin (ENF) on the erythrocyte cellular and nuclear morphometric anomalies in Oreochromis niloticus. Fish were fed graded doses of ENF at 0 mg, 10 mg, 30 mg, 50 mg and 100 mg kg biomass–1 day–1 for 15 consecutive days, followed by a 21-day post-dosing observation. The results revealed significant alterations in erythrocyte morphometric characteristics, such as major and minor axes, volume, surface area, cell to nucleus ratio, and surface area to volume ratio due to dietary ENF, indicating its cytotoxicity and perilous effects on fish erythrocytes. The nucleus was shrinking more significantly than the cell under treatment-induced stress. On day 15 of dosing, the surface area to volume ratio increased in the dosing groups, except for the 10× group, which represented an adaptive response in the fish to facilitate greater area for gas exchange to occur. However, the observed dose- and time-dependent erythro-morphometry was reversible once dosing was suspended. The results showed that fish erythrometric abnormalities, a relatively unexplored area of clinical science, can serve as important biomarkers or sensitive indicators of toxicity of veterinary medicinal products in assessing the physiological health status of cultured aquatic organisms.
- Open Access
- 10 April 2026
- Published by Springer Nature in Animal Diseases
- Vol. 6 (1)
Florfenicol in aquaculture: environmental fate of residues and dissemination of antimicrobial resistance genes
Florfenicol (FFC) has become a significant antibiotic in the global aquaculture industry, particularly in the treatment of bacterial infections in finfish and shellfish. FFC is valued for its broad-spectrum bacteriostatic activity and effectiveness. This comprehensive review consolidates and expands upon existing research, offering in-depth information on FFC application across various aquaculture practices. This review addresses the key pharmacokinetic aspects of FFC, such as its absorption, distribution, metabolism, and excretion, in aquatic species. Significant attention is given to the safety profile of FFC, with discussions on residue accumulation, elimination dynamics, and the established withdrawal periods necessary to ensure consumer safety. Furthermore, this review highlights emerging issues related to FFC in aquaculture, particularly with respect to plasmid-mediated resistance, the dispersal of resistant bacteria and resistance genes, and their impact on the aquatic environment and nontarget organisms, laying a foundation for future research in this critical area. This evaluative assessment offers a novel contribution to the field, serving as an essential reference for ongoing and future studies on the appropriate use and prevention of FFC resistance in aquatic animal medicine.
- 10 April 2026
- Published by Springer Nature in Animal Diseases
- Vol. 6 (1)
Open AccessFlorfenicol in aquaculture: environmental fate of residues and dissemination of antimicrobial resistance genes
Florfenicol (FFC) has become a significant antibiotic in the global aquaculture industry, particularly in the treatment of bacterial infections in finfish and shellfish. FFC is valued for its broad-spectrum bacteriostatic activity and effectiveness. This comprehensive review consolidates and expands upon existing research, offering in-depth information on FFC application across various aquaculture practices. This review addresses the key pharmacokinetic aspects of FFC, such as its absorption, distribution, metabolism, and excretion, in aquatic species. Significant attention is given to the safety profile of FFC, with discussions on residue accumulation, elimination dynamics, and the established withdrawal periods necessary to ensure consumer safety. Furthermore, this review highlights emerging issues related to FFC in aquaculture, particularly with respect to plasmid-mediated resistance, the dispersal of resistant bacteria and resistance genes, and their impact on the aquatic environment and nontarget organisms, laying a foundation for future research in this critical area. This evaluative assessment offers a novel contribution to the field, serving as an essential reference for ongoing and future studies on the appropriate use and prevention of FFC resistance in aquatic animal medicine.
- Open Access
- 8 April 2026
- Published by Wiley in Animal Research and One Health
Use of Clotrimazole in Finfish Aquaculture: Mechanistic Insights, Limitations, and Future Directions for Antifungal Therapy
Fungal infections, including saprolegniasis and opportunistic mycoses, pose persistent challenges in aquaculture, driving the search for effective and safe antifungal agents. Clotrimazole (CLO), a clinically established imidazole, exhibits broad‐spectrum antifungal activity by inhibiting sterol 14α‐demethylase, disrupting ergosterol biosynthesis, and compromising fungal cell membrane integrity. This review synthesizes current knowledge on CLO's potential role in fungal disease, particularly saprolegniasis management, highlighting mechanistic plausibility alongside significant limitations largely based on in vitro and mechanistic data. Key challenges include the paucity of replicated in vivo efficacy and toxicokinetic data in representative aquaculture species, unresolved residue and food‐safety considerations, regulatory constraints, and potential environmental impacts, including selection for antifungal resistance. This review examines pharmacokinetic and pharmacodynamic considerations, environmental fate, and ecotoxicological risks, emphasizing the need for closed‐system testing and targeted delivery to mitigate off‐target exposure. Future research directions focus on species‐specific in vivo trials, good laboratory practice‐compliant residue and tissue distribution studies, advanced formulation strategies such as mucoadhesive carriers and nanoparticle delivery, and integrated One Health‐oriented stewardship frameworks, including resistance monitoring. By framing CLO as a conditional candidate for controlled aquaculture use, this review provides a comprehensive blueprint for rational evaluation, highlighting the balance between therapeutic promise and precautionary risk management in aquatic veterinary pharmacology, and offers a scientific basis for future research priorities and informed policy decisions.
- 8 April 2026
- Published by Wiley in Animal Research and One Health
Open AccessUse of Clotrimazole in Finfish Aquaculture: Mechanistic Insights, Limitations, and Future Directions for Antifungal Therapy
Fungal infections, including saprolegniasis and opportunistic mycoses, pose persistent challenges in aquaculture, driving the search for effective and safe antifungal agents. Clotrimazole (CLO), a clinically established imidazole, exhibits broad‐spectrum antifungal activity by inhibiting sterol 14α‐demethylase, disrupting ergosterol biosynthesis, and compromising fungal cell membrane integrity. This review synthesizes current knowledge on CLO's potential role in fungal disease, particularly saprolegniasis management, highlighting mechanistic plausibility alongside significant limitations largely based on in vitro and mechanistic data. Key challenges include the paucity of replicated in vivo efficacy and toxicokinetic data in representative aquaculture species, unresolved residue and food‐safety considerations, regulatory constraints, and potential environmental impacts, including selection for antifungal resistance. This review examines pharmacokinetic and pharmacodynamic considerations, environmental fate, and ecotoxicological risks, emphasizing the need for closed‐system testing and targeted delivery to mitigate off‐target exposure. Future research directions focus on species‐specific in vivo trials, good laboratory practice‐compliant residue and tissue distribution studies, advanced formulation strategies such as mucoadhesive carriers and nanoparticle delivery, and integrated One Health‐oriented stewardship frameworks, including resistance monitoring. By framing CLO as a conditional candidate for controlled aquaculture use, this review provides a comprehensive blueprint for rational evaluation, highlighting the balance between therapeutic promise and precautionary risk management in aquatic veterinary pharmacology, and offers a scientific basis for future research priorities and informed policy decisions.
- 20 January 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (3) , 333-342
Pharmacokinetics and Tissue Residue Profiles of Enrofloxacin in Nile Tilapia Oreochromis niloticus Following a Single Oral Administration
The increasing frequency of bacterial diseases in aquaculture has necessitated the use of several antibiotics, including enrofloxacin (ENF), a broad‐spectrum fluoroquinolone. The pharmacokinetic (PK) and pharmacodynamic (PD) data on ENF under tropical aquaculture conditions remain scarce. This study investigated the PK profile, tissue accumulation, and depletion pattern of total active fluoroquinolone (ENF + CIP) in Nile tilapia Oreochromis niloticus following a single oral dose of 10 mg/kg biomass. The ENF demonstrated rapid absorption, with peak plasma concentration ( C max ) of 1.33 ± 0.21 μg/mL at 0.59 h ( T max ), and extensive tissue distribution, particularly in bile ( C max : 16.26 ± 0.50 μg/mL) and intestine ( C max : 7.08 ± 0.28 μg/g). Elimination half‐lives ( t 1/2 β ) varied among tissues, with prolonged persistence in skin ( t 1/2 β : 693.18 h) and gills ( t 1/2 β : 237.47 h), indicating slow depletion. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of ENF indicated its high effectiveness against Aeromonas hydrophila (0.20 μg/mL), while Streptococcus agalactiae exhibited comparatively lower sensitivity (MIC: 1.56 μg/mL; MBC: 6.25 μg/mL). The PK/PD integration revealed that ENF achieved optimal therapeutic levels against A. hydrophila , but suboptimal levels for S. agalactiae under a single‐dose regimen. These findings underscore the need for tailored dosing strategies and highlight the importance of pharmacokinetic and microbiological data for responsible antibiotic use in aquaculture.
- 20 January 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (3) , 333-342
Pharmacokinetics and Tissue Residue Profiles of Enrofloxacin in Nile Tilapia Oreochromis niloticus Following a Single Oral Administration
The increasing frequency of bacterial diseases in aquaculture has necessitated the use of several antibiotics, including enrofloxacin (ENF), a broad‐spectrum fluoroquinolone. The pharmacokinetic (PK) and pharmacodynamic (PD) data on ENF under tropical aquaculture conditions remain scarce. This study investigated the PK profile, tissue accumulation, and depletion pattern of total active fluoroquinolone (ENF + CIP) in Nile tilapia Oreochromis niloticus following a single oral dose of 10 mg/kg biomass. The ENF demonstrated rapid absorption, with peak plasma concentration ( C max ) of 1.33 ± 0.21 μg/mL at 0.59 h ( T max ), and extensive tissue distribution, particularly in bile ( C max : 16.26 ± 0.50 μg/mL) and intestine ( C max : 7.08 ± 0.28 μg/g). Elimination half‐lives ( t 1/2 β ) varied among tissues, with prolonged persistence in skin ( t 1/2 β : 693.18 h) and gills ( t 1/2 β : 237.47 h), indicating slow depletion. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of ENF indicated its high effectiveness against Aeromonas hydrophila (0.20 μg/mL), while Streptococcus agalactiae exhibited comparatively lower sensitivity (MIC: 1.56 μg/mL; MBC: 6.25 μg/mL). The PK/PD integration revealed that ENF achieved optimal therapeutic levels against A. hydrophila , but suboptimal levels for S. agalactiae under a single‐dose regimen. These findings underscore the need for tailored dosing strategies and highlight the importance of pharmacokinetic and microbiological data for responsible antibiotic use in aquaculture.
- 8 November 2025
- Published by Springer Nature in Journal of Ocean University of China
- Vol. 24 (6) , 1719-1727
Florfenicol Therapy Reduces Brain Histoarchitectural Anomalies in Streptococcus agalactiae-Infected Nile Tilapia Oreochromis niloticus
- 8 November 2025
- Published by Springer Nature in Journal of Ocean University of China
- Vol. 24 (6) , 1719-1727
Florfenicol Therapy Reduces Brain Histoarchitectural Anomalies in Streptococcus agalactiae-Infected Nile Tilapia Oreochromis niloticus
- Open Access
- 18 October 2025
- Published by International Library of Science in Highlights in BioScience
- Vol. 8
Influence of in-feed oxolinic acid therapy on the brain histoarchitecture and virulence factors of Streptococcus agalactiae infecting Nile tilapia Oreochromis niloticus
Streptococcosis and its management are major constraints to tilapia aquaculture. The present study assessed the effect of oral administration of 12 mg oxolinic acid (OA)/kg fish/day for 7 uninterrupted days against Streptococcus agalactiae LCR1 (Sa) infection and its influence on histopathological anomalies in the forebrain, optic tectum region of the mid-brain and granular cell layer of the cerebellum of Oreochromis niloticus. Besides, attempts were made to understand how the OA impacts the glycosyltransferases and CAMP factor of S. agalactiae through molecular docking. The LD₅₀ of Sa was 1.26 × 10⁸ cells/fish. Sa infection was apparent in OA-treated and untreated groups, and the brain tissues exhibited the progression and reversal of meningitis. The forebrain exhibited thickening of the meninx primitiva, vacuolation, and degeneration in the brain parenchyma and meninx primitiva. Inflammatory changes such as meningitis and mononuclear cell infiltration were documented. The midbrain had edematous optic tectum, loosening of connective tissue, and leukocyte infiltration. In the granular cell layer, cerebellum changes such as spongiform encephalopathy and necrosis indicate region-specific damage. However, the OA effectively reduced the severity of brain tissue damage, possibly by its binding affinities and upsetting the activities of glycosyltransferases and CAMP factor, as confirmed by molecular docking. These results confirmed that OA can cross the blood-brain barrier and interact with virulence proteins to reduce the Sa infection in the brain. Furthermore, the results underscore its responsible use in aquaculture, as OA is a critically important human medicine and ought to be used as a secondary treatment.
- 18 October 2025
- Published by International Library of Science in Highlights in BioScience
- Vol. 8
Open AccessInfluence of in-feed oxolinic acid therapy on the brain histoarchitecture and virulence factors of Streptococcus agalactiae infecting Nile tilapia Oreochromis niloticus
Streptococcosis and its management are major constraints to tilapia aquaculture. The present study assessed the effect of oral administration of 12 mg oxolinic acid (OA)/kg fish/day for 7 uninterrupted days against Streptococcus agalactiae LCR1 (Sa) infection and its influence on histopathological anomalies in the forebrain, optic tectum region of the mid-brain and granular cell layer of the cerebellum of Oreochromis niloticus. Besides, attempts were made to understand how the OA impacts the glycosyltransferases and CAMP factor of S. agalactiae through molecular docking. The LD₅₀ of Sa was 1.26 × 10⁸ cells/fish. Sa infection was apparent in OA-treated and untreated groups, and the brain tissues exhibited the progression and reversal of meningitis. The forebrain exhibited thickening of the meninx primitiva, vacuolation, and degeneration in the brain parenchyma and meninx primitiva. Inflammatory changes such as meningitis and mononuclear cell infiltration were documented. The midbrain had edematous optic tectum, loosening of connective tissue, and leukocyte infiltration. In the granular cell layer, cerebellum changes such as spongiform encephalopathy and necrosis indicate region-specific damage. However, the OA effectively reduced the severity of brain tissue damage, possibly by its binding affinities and upsetting the activities of glycosyltransferases and CAMP factor, as confirmed by molecular docking. These results confirmed that OA can cross the blood-brain barrier and interact with virulence proteins to reduce the Sa infection in the brain. Furthermore, the results underscore its responsible use in aquaculture, as OA is a critically important human medicine and ought to be used as a secondary treatment.